In accordance, we found elevated levels of SPARC mRNA melanoma samples from patients in advanced stages of the disease (Figure 1A–C) as well as in invasive melanoma cell lines (Figure 1D) (all clinical and histological characteristics of melanoma samples are described in Supplementary Table S1). This evidence concerns the gene SPARC and melanoma.